IPMN, PANCREATIC
Clinical trials for IPMN, PANCREATIC explained in plain language.
Never miss a new study
Get alerted when new IPMN, PANCREATIC trials appear
Sign up with your email to follow new studies for IPMN, PANCREATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Hope for pancreatic cancer prevention: old drug, new trial
Prevention OngoingThis study tests whether the anti-inflammatory drug sulindac can prevent high-risk pancreatic cysts (IPMNs) from progressing to pancreatic cancer. About 100 adults with these cysts will receive either sulindac or a placebo for up to 3 years, alongside standard monitoring. The goa…
Matched conditions: IPMN, PANCREATIC
Phase: PHASE2 • Sponsor: Duke University • Aim: Prevention
Last updated Jun 27, 2026 13:02 UTC
-
Vitamin e derivative tested to halt pancreatic cyst growth
Prevention OngoingThis study tests whether a natural compound called delta-tocotrienol (a form of vitamin E) can prevent pancreatic cysts (IPMNs) from growing or turning into cancer. About 4 adults with IPMNs that are being watched but not yet dangerous will receive either the supplement or a plac…
Matched conditions: IPMN, PANCREATIC
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Prevention
Last updated Jun 27, 2026 07:57 UTC